HEADER HYDROLASE 04-JUN-07 2Q6D TITLE CRYSTAL STRUCTURE OF INFECTIOUS BRONCHITIS VIRUS (IBV) MAIN PROTEASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: INFECTIOUS BRONCHITIS VIRUS (IBV) MAIN PROTEASE; COMPND 3 CHAIN: A, B, C; COMPND 4 SYNONYM: FRAGMENT; COMPND 5 EC: 3.4.22.-; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: INFECTIOUS BRONCHITIS VIRUS; SOURCE 3 ORGANISM_TAXID: 11120; SOURCE 4 STRAIN: M41; SOURCE 5 GENE: M41 3C-LIKE PROTEASE GENE; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGEX-4T-1 KEYWDS CORONAVIRUS; IBV; MAIN PROTEASE; 3C-LIKE PROTEINASE, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR X.Y.XUE,H.T.YANG,F.XUE,M.BARTLAM,Z.H.RAO REVDAT 4 30-AUG-23 2Q6D 1 SEQADV REVDAT 3 24-FEB-09 2Q6D 1 VERSN REVDAT 2 25-MAR-08 2Q6D 1 JRNL REVDAT 1 12-FEB-08 2Q6D 0 JRNL AUTH X.XUE,H.YU,H.YANG,F.XUE,Z.WU,W.SHEN,J.LI,Z.ZHOU,Y.DING, JRNL AUTH 2 Q.ZHAO,X.C.ZHANG,M.LIAO,M.BARTLAM,Z.RAO JRNL TITL STRUCTURES OF TWO CORONAVIRUS MAIN PROTEASES: IMPLICATIONS JRNL TITL 2 FOR SUBSTRATE BINDING AND ANTIVIRAL DRUG DESIGN. JRNL REF J.VIROL. V. 82 2515 2008 JRNL REFN ISSN 0022-538X JRNL PMID 18094151 JRNL DOI 10.1128/JVI.02114-07 REMARK 2 REMARK 2 RESOLUTION. 2.35 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.35 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.6 REMARK 3 NUMBER OF REFLECTIONS : 45866 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.226 REMARK 3 FREE R VALUE : 0.259 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 4648 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6949 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 566 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2Q6D COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-JUL-07. REMARK 100 THE DEPOSITION ID IS D_1000043205. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-MAR-07; 12-DEC-05 REMARK 200 TEMPERATURE (KELVIN) : 100; 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 2 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y; Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY; APS REMARK 200 BEAMLINE : BL-5A; 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL; NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M; M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000; 0.9795 REMARK 200 MONOCHROMATOR : NULL; NULL REMARK 200 OPTICS : NULL; NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD; CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315; SBC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 47480 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.350 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 200 DATA REDUNDANCY : 7.200 REMARK 200 R MERGE (I) : 0.05400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.35 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.43 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 7.30 REMARK 200 R MERGE FOR SHELL (I) : 0.35800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 5.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH; MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD AND MOLECULAR REMARK 200 REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1P9S REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.07 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.74 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 5% PEG 4000, 12% 2-PROPANOL, 0.1 M REMARK 280 SODIUM CACODYLATE PH 6.5., VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 7555 Y,X,-Z+1/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+2/3 REMARK 290 10555 -Y,-X,-Z+5/6 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 90.28733 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 180.57467 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 135.43100 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 225.71833 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 45.14367 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 90.28733 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 180.57467 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 225.71833 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 135.43100 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 45.14367 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A DIMER:MONOMER STRUCTURE WITH REMARK 300 THE MONOMER'S C TERMINUS INSERTED INTO THE ACTIVE SITE OF THE DIMER. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH C 472 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 LYS A 214 REMARK 465 GLU A 215 REMARK 465 SER A 216 REMARK 465 SER A 217 REMARK 465 PHE A 218 REMARK 465 GLY A 302 REMARK 465 GLY A 303 REMARK 465 VAL A 304 REMARK 465 ARG A 305 REMARK 465 LEU A 306 REMARK 465 GLN A 307 REMARK 465 GLY B -1 REMARK 465 GLN B 307 REMARK 465 GLY C -1 REMARK 465 SER C 0 REMARK 465 SER C 1 REMARK 465 GLY C 2 REMARK 465 PHE C 3 REMARK 465 LYS C 4 REMARK 465 LYS C 5 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 435 O HOH A 438 0.26 REMARK 500 C VAL A 213 O HOH A 430 1.51 REMARK 500 CB THR B 127 O HOH B 483 2.06 REMARK 500 CB CYS C 143 O HOH C 501 2.09 REMARK 500 O SER A 279 O HOH A 446 2.10 REMARK 500 CD1 LEU C 55 O HOH C 502 2.10 REMARK 500 CG1 ILE C 252 O HOH C 478 2.11 REMARK 500 O VAL A 213 O HOH A 430 2.13 REMARK 500 CD1 LEU B 175 O HOH B 493 2.14 REMARK 500 O LYS C 214 N SER C 217 2.17 REMARK 500 O HOH B 399 O HOH B 463 2.18 REMARK 500 OG1 THR A 127 OE2 GLU A 291 2.19 REMARK 500 O HOH A 342 O HOH C 506 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 THR A 244 C PRO A 245 N -0.121 REMARK 500 ASP C 49 C GLN C 50 N -0.219 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 TRP A 223 N - CA - CB ANGL. DEV. = -11.0 DEGREES REMARK 500 LEU B 175 CA - CB - CG ANGL. DEV. = -14.4 DEGREES REMARK 500 ALA B 189 CB - CA - C ANGL. DEV. = -26.1 DEGREES REMARK 500 GLN B 190 N - CA - CB ANGL. DEV. = -13.6 DEGREES REMARK 500 PRO B 193 C - N - CA ANGL. DEV. = 9.4 DEGREES REMARK 500 LEU C 6 CA - C - N ANGL. DEV. = -15.3 DEGREES REMARK 500 ASP C 49 CB - CA - C ANGL. DEV. = -12.6 DEGREES REMARK 500 ASP C 49 O - C - N ANGL. DEV. = -15.1 DEGREES REMARK 500 GLN C 50 N - CA - CB ANGL. DEV. = 12.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 22 -115.96 -123.56 REMARK 500 LEU A 139 65.82 -104.72 REMARK 500 SER A 239 -4.98 -57.90 REMARK 500 VAL A 261 125.84 -31.70 REMARK 500 HIS B 41 2.11 -65.61 REMARK 500 SER B 47 -179.20 -170.91 REMARK 500 GLU B 95 53.06 -119.88 REMARK 500 TYR B 124 146.35 -171.85 REMARK 500 ALA B 136 -169.01 -125.98 REMARK 500 PRO B 166 157.57 -43.60 REMARK 500 ASN B 167 60.01 69.89 REMARK 500 GLU B 187 53.51 -104.18 REMARK 500 VAL B 188 -93.64 -118.36 REMARK 500 PRO B 193 -170.54 -59.27 REMARK 500 SER C 47 -157.87 -168.08 REMARK 500 ASP C 49 -12.52 78.79 REMARK 500 ALA C 94 5.26 -68.42 REMARK 500 ALA C 136 108.57 -167.34 REMARK 500 HIS C 162 -57.60 -125.85 REMARK 500 SER C 217 -5.07 85.58 REMARK 500 PHE C 218 -74.96 -93.74 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLY A 48 ASP A 49 -143.83 REMARK 500 SER C 216 SER C 217 146.61 REMARK 500 SER C 217 PHE C 218 -142.70 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 ASP C 49 18.87 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2Q6F RELATED DB: PDB REMARK 900 RELATED ID: 2Q6G RELATED DB: PDB DBREF 2Q6D A 1 307 UNP Q3Y5H1 Q3Y5H1_9CORO 1 307 DBREF 2Q6D B 1 307 UNP Q3Y5H1 Q3Y5H1_9CORO 1 307 DBREF 2Q6D C 1 307 UNP Q3Y5H1 Q3Y5H1_9CORO 1 307 SEQADV 2Q6D GLY A -1 UNP Q3Y5H1 EXPRESSION TAG SEQADV 2Q6D SER A 0 UNP Q3Y5H1 EXPRESSION TAG SEQADV 2Q6D GLY B -1 UNP Q3Y5H1 EXPRESSION TAG SEQADV 2Q6D SER B 0 UNP Q3Y5H1 EXPRESSION TAG SEQADV 2Q6D GLY C -1 UNP Q3Y5H1 EXPRESSION TAG SEQADV 2Q6D SER C 0 UNP Q3Y5H1 EXPRESSION TAG SEQRES 1 A 309 GLY SER SER GLY PHE LYS LYS LEU VAL SER PRO SER SER SEQRES 2 A 309 ALA VAL GLU LYS CYS ILE VAL SER VAL SER TYR ARG GLY SEQRES 3 A 309 ASN ASN LEU ASN GLY LEU TRP LEU GLY ASP SER ILE TYR SEQRES 4 A 309 CYS PRO ARG HIS VAL LEU GLY LYS PHE SER GLY ASP GLN SEQRES 5 A 309 TRP GLY ASP VAL LEU ASN LEU ALA ASN ASN HIS GLU PHE SEQRES 6 A 309 GLU VAL VAL THR GLN ASN GLY VAL THR LEU ASN VAL VAL SEQRES 7 A 309 SER ARG ARG LEU LYS GLY ALA VAL LEU ILE LEU GLN THR SEQRES 8 A 309 ALA VAL ALA ASN ALA GLU THR PRO LYS TYR LYS PHE VAL SEQRES 9 A 309 LYS ALA ASN CYS GLY ASP SER PHE THR ILE ALA CYS SER SEQRES 10 A 309 TYR GLY GLY THR VAL ILE GLY LEU TYR PRO VAL THR MET SEQRES 11 A 309 ARG SER ASN GLY THR ILE ARG ALA SER PHE LEU ALA GLY SEQRES 12 A 309 ALA CYS GLY SER VAL GLY PHE ASN ILE GLU LYS GLY VAL SEQRES 13 A 309 VAL ASN PHE PHE TYR MET HIS HIS LEU GLU LEU PRO ASN SEQRES 14 A 309 ALA LEU HIS THR GLY THR ASP LEU MET GLY GLU PHE TYR SEQRES 15 A 309 GLY GLY TYR VAL ASP GLU GLU VAL ALA GLN ARG VAL PRO SEQRES 16 A 309 PRO ASP ASN LEU VAL THR ASN ASN ILE VAL ALA TRP LEU SEQRES 17 A 309 TYR ALA ALA ILE ILE SER VAL LYS GLU SER SER PHE SER SEQRES 18 A 309 GLN PRO LYS TRP LEU GLU SER THR THR VAL SER ILE GLU SEQRES 19 A 309 ASP TYR ASN ARG TRP ALA SER ASP ASN GLY PHE THR PRO SEQRES 20 A 309 PHE SER THR SER THR ALA ILE THR LYS LEU SER ALA ILE SEQRES 21 A 309 THR GLY VAL ASP VAL CYS LYS LEU LEU ARG THR ILE MET SEQRES 22 A 309 VAL LYS SER ALA GLN TRP GLY SER ASP PRO ILE LEU GLY SEQRES 23 A 309 GLN TYR ASN PHE GLU ASP GLU LEU THR PRO GLU SER VAL SEQRES 24 A 309 PHE ASN GLN VAL GLY GLY VAL ARG LEU GLN SEQRES 1 B 309 GLY SER SER GLY PHE LYS LYS LEU VAL SER PRO SER SER SEQRES 2 B 309 ALA VAL GLU LYS CYS ILE VAL SER VAL SER TYR ARG GLY SEQRES 3 B 309 ASN ASN LEU ASN GLY LEU TRP LEU GLY ASP SER ILE TYR SEQRES 4 B 309 CYS PRO ARG HIS VAL LEU GLY LYS PHE SER GLY ASP GLN SEQRES 5 B 309 TRP GLY ASP VAL LEU ASN LEU ALA ASN ASN HIS GLU PHE SEQRES 6 B 309 GLU VAL VAL THR GLN ASN GLY VAL THR LEU ASN VAL VAL SEQRES 7 B 309 SER ARG ARG LEU LYS GLY ALA VAL LEU ILE LEU GLN THR SEQRES 8 B 309 ALA VAL ALA ASN ALA GLU THR PRO LYS TYR LYS PHE VAL SEQRES 9 B 309 LYS ALA ASN CYS GLY ASP SER PHE THR ILE ALA CYS SER SEQRES 10 B 309 TYR GLY GLY THR VAL ILE GLY LEU TYR PRO VAL THR MET SEQRES 11 B 309 ARG SER ASN GLY THR ILE ARG ALA SER PHE LEU ALA GLY SEQRES 12 B 309 ALA CYS GLY SER VAL GLY PHE ASN ILE GLU LYS GLY VAL SEQRES 13 B 309 VAL ASN PHE PHE TYR MET HIS HIS LEU GLU LEU PRO ASN SEQRES 14 B 309 ALA LEU HIS THR GLY THR ASP LEU MET GLY GLU PHE TYR SEQRES 15 B 309 GLY GLY TYR VAL ASP GLU GLU VAL ALA GLN ARG VAL PRO SEQRES 16 B 309 PRO ASP ASN LEU VAL THR ASN ASN ILE VAL ALA TRP LEU SEQRES 17 B 309 TYR ALA ALA ILE ILE SER VAL LYS GLU SER SER PHE SER SEQRES 18 B 309 GLN PRO LYS TRP LEU GLU SER THR THR VAL SER ILE GLU SEQRES 19 B 309 ASP TYR ASN ARG TRP ALA SER ASP ASN GLY PHE THR PRO SEQRES 20 B 309 PHE SER THR SER THR ALA ILE THR LYS LEU SER ALA ILE SEQRES 21 B 309 THR GLY VAL ASP VAL CYS LYS LEU LEU ARG THR ILE MET SEQRES 22 B 309 VAL LYS SER ALA GLN TRP GLY SER ASP PRO ILE LEU GLY SEQRES 23 B 309 GLN TYR ASN PHE GLU ASP GLU LEU THR PRO GLU SER VAL SEQRES 24 B 309 PHE ASN GLN VAL GLY GLY VAL ARG LEU GLN SEQRES 1 C 309 GLY SER SER GLY PHE LYS LYS LEU VAL SER PRO SER SER SEQRES 2 C 309 ALA VAL GLU LYS CYS ILE VAL SER VAL SER TYR ARG GLY SEQRES 3 C 309 ASN ASN LEU ASN GLY LEU TRP LEU GLY ASP SER ILE TYR SEQRES 4 C 309 CYS PRO ARG HIS VAL LEU GLY LYS PHE SER GLY ASP GLN SEQRES 5 C 309 TRP GLY ASP VAL LEU ASN LEU ALA ASN ASN HIS GLU PHE SEQRES 6 C 309 GLU VAL VAL THR GLN ASN GLY VAL THR LEU ASN VAL VAL SEQRES 7 C 309 SER ARG ARG LEU LYS GLY ALA VAL LEU ILE LEU GLN THR SEQRES 8 C 309 ALA VAL ALA ASN ALA GLU THR PRO LYS TYR LYS PHE VAL SEQRES 9 C 309 LYS ALA ASN CYS GLY ASP SER PHE THR ILE ALA CYS SER SEQRES 10 C 309 TYR GLY GLY THR VAL ILE GLY LEU TYR PRO VAL THR MET SEQRES 11 C 309 ARG SER ASN GLY THR ILE ARG ALA SER PHE LEU ALA GLY SEQRES 12 C 309 ALA CYS GLY SER VAL GLY PHE ASN ILE GLU LYS GLY VAL SEQRES 13 C 309 VAL ASN PHE PHE TYR MET HIS HIS LEU GLU LEU PRO ASN SEQRES 14 C 309 ALA LEU HIS THR GLY THR ASP LEU MET GLY GLU PHE TYR SEQRES 15 C 309 GLY GLY TYR VAL ASP GLU GLU VAL ALA GLN ARG VAL PRO SEQRES 16 C 309 PRO ASP ASN LEU VAL THR ASN ASN ILE VAL ALA TRP LEU SEQRES 17 C 309 TYR ALA ALA ILE ILE SER VAL LYS GLU SER SER PHE SER SEQRES 18 C 309 GLN PRO LYS TRP LEU GLU SER THR THR VAL SER ILE GLU SEQRES 19 C 309 ASP TYR ASN ARG TRP ALA SER ASP ASN GLY PHE THR PRO SEQRES 20 C 309 PHE SER THR SER THR ALA ILE THR LYS LEU SER ALA ILE SEQRES 21 C 309 THR GLY VAL ASP VAL CYS LYS LEU LEU ARG THR ILE MET SEQRES 22 C 309 VAL LYS SER ALA GLN TRP GLY SER ASP PRO ILE LEU GLY SEQRES 23 C 309 GLN TYR ASN PHE GLU ASP GLU LEU THR PRO GLU SER VAL SEQRES 24 C 309 PHE ASN GLN VAL GLY GLY VAL ARG LEU GLN FORMUL 4 HOH *566(H2 O) HELIX 1 1 SER A 10 LYS A 15 1 6 HELIX 2 2 HIS A 41 GLY A 44 5 4 HELIX 3 3 GLN A 50 ALA A 58 1 9 HELIX 4 4 ASN A 59 PHE A 63 5 5 HELIX 5 5 PHE A 179 TYR A 183 5 5 HELIX 6 6 VAL A 198 VAL A 213 1 16 HELIX 7 7 SER A 230 SER A 239 1 10 HELIX 8 8 SER A 249 THR A 259 1 11 HELIX 9 9 ASP A 262 GLN A 276 1 15 HELIX 10 10 THR A 293 GLN A 300 1 8 HELIX 11 11 SER B 10 LYS B 15 1 6 HELIX 12 12 HIS B 41 GLY B 44 5 4 HELIX 13 13 ASP B 49 ALA B 58 1 10 HELIX 14 14 ASN B 59 HIS B 61 5 3 HELIX 15 15 VAL B 198 GLU B 215 1 18 HELIX 16 16 SER B 230 ASP B 240 1 11 HELIX 17 17 SER B 249 LEU B 255 1 7 HELIX 18 18 LEU B 255 GLY B 260 1 6 HELIX 19 19 ASP B 262 GLN B 276 1 15 HELIX 20 20 THR B 293 GLY B 302 1 10 HELIX 21 21 SER C 8 LYS C 15 1 8 HELIX 22 22 HIS C 41 GLY C 44 5 4 HELIX 23 23 GLN C 50 ALA C 58 1 9 HELIX 24 24 SER C 137 ALA C 140 5 4 HELIX 25 25 ASP C 185 GLN C 190 1 6 HELIX 26 26 VAL C 198 GLU C 215 1 18 HELIX 27 27 SER C 230 ASN C 241 1 12 HELIX 28 28 SER C 249 GLY C 260 1 12 HELIX 29 29 ASP C 262 GLN C 276 1 15 HELIX 30 30 THR C 293 GLY C 303 1 11 SHEET 1 A 7 THR A 72 LEU A 73 0 SHEET 2 A 7 GLU A 64 VAL A 66 -1 N VAL A 65 O LEU A 73 SHEET 3 A 7 ILE A 17 SER A 21 -1 N SER A 19 O VAL A 66 SHEET 4 A 7 ASN A 26 LEU A 32 -1 O LEU A 27 N VAL A 20 SHEET 5 A 7 SER A 35 PRO A 39 -1 O TYR A 37 N LEU A 30 SHEET 6 A 7 VAL A 84 THR A 89 -1 O LEU A 85 N CYS A 38 SHEET 7 A 7 VAL A 75 LYS A 81 -1 N VAL A 76 O GLN A 88 SHEET 1 B 5 TYR A 99 PHE A 101 0 SHEET 2 B 5 VAL A 154 GLU A 164 1 O PHE A 157 N LYS A 100 SHEET 3 B 5 VAL A 146 GLU A 151 -1 N ASN A 149 O ASN A 156 SHEET 4 B 5 SER A 109 TYR A 116 -1 N THR A 111 O PHE A 148 SHEET 5 B 5 THR A 119 THR A 127 -1 O TYR A 124 N ILE A 112 SHEET 1 C 4 TYR A 99 PHE A 101 0 SHEET 2 C 4 VAL A 154 GLU A 164 1 O PHE A 157 N LYS A 100 SHEET 3 C 4 LEU A 169 THR A 173 -1 O THR A 171 N LEU A 163 SHEET 4 C 4 ILE A 134 ARG A 135 -1 N ILE A 134 O HIS A 170 SHEET 1 D 7 THR B 72 LEU B 73 0 SHEET 2 D 7 PHE B 63 VAL B 66 -1 N VAL B 65 O LEU B 73 SHEET 3 D 7 ILE B 17 TYR B 22 -1 N SER B 21 O GLU B 64 SHEET 4 D 7 ASN B 25 LEU B 32 -1 O GLY B 29 N VAL B 18 SHEET 5 D 7 SER B 35 PRO B 39 -1 O TYR B 37 N LEU B 30 SHEET 6 D 7 VAL B 84 THR B 89 -1 O LEU B 87 N ILE B 36 SHEET 7 D 7 VAL B 75 LYS B 81 -1 N VAL B 76 O GLN B 88 SHEET 1 E 5 TYR B 99 PHE B 101 0 SHEET 2 E 5 VAL B 154 LEU B 165 1 O PHE B 157 N LYS B 100 SHEET 3 E 5 VAL B 146 GLU B 151 -1 N ASN B 149 O ASN B 156 SHEET 4 E 5 SER B 109 TYR B 116 -1 N THR B 111 O PHE B 148 SHEET 5 E 5 THR B 119 THR B 127 -1 O TYR B 124 N ILE B 112 SHEET 1 F 3 TYR B 99 PHE B 101 0 SHEET 2 F 3 VAL B 154 LEU B 165 1 O PHE B 157 N LYS B 100 SHEET 3 F 3 LEU B 169 THR B 173 -1 O THR B 171 N LEU B 163 SHEET 1 G 6 GLU C 64 VAL C 66 0 SHEET 2 G 6 ILE C 17 SER C 21 -1 N SER C 21 O GLU C 64 SHEET 3 G 6 LEU C 27 LEU C 32 -1 O GLY C 29 N VAL C 18 SHEET 4 G 6 SER C 35 PRO C 39 -1 O TYR C 37 N LEU C 30 SHEET 5 G 6 VAL C 84 THR C 89 -1 O LEU C 85 N CYS C 38 SHEET 6 G 6 VAL C 75 LYS C 81 -1 N LYS C 81 O VAL C 84 SHEET 1 H 5 TYR C 99 PHE C 101 0 SHEET 2 H 5 VAL C 154 LEU C 165 1 O PHE C 157 N LYS C 100 SHEET 3 H 5 VAL C 146 GLU C 151 -1 N GLU C 151 O VAL C 154 SHEET 4 H 5 SER C 109 TYR C 116 -1 N THR C 111 O PHE C 148 SHEET 5 H 5 THR C 119 THR C 127 -1 O ILE C 121 N CYS C 114 SHEET 1 I 4 TYR C 99 PHE C 101 0 SHEET 2 I 4 VAL C 154 LEU C 165 1 O PHE C 157 N LYS C 100 SHEET 3 I 4 LEU C 169 THR C 173 -1 O LEU C 169 N LEU C 165 SHEET 4 I 4 ILE C 134 ARG C 135 -1 N ILE C 134 O HIS C 170 CISPEP 1 GLY C 48 ASP C 49 0 2.05 CRYST1 118.900 118.900 270.862 90.00 90.00 120.00 P 61 2 2 36 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008410 0.004856 0.000000 0.00000 SCALE2 0.000000 0.009712 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003692 0.00000